The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure
Rudyk, B.I.; Sabadyshin, R.A.
Likars'ka Sprava 4: 25-28
1992
ISSN/ISBN: 1019-5297 PMID: 1441362 Document Number: 4769
It was found that emoxypin (40 mg daily) with nitrates of prolonged action and corinfar used in 87 patients with chronic cardiac insufficiency (CCI) reduces the concentration of primary and secondary products of lipid peroxidation to control levels which is not observed when only corinfar and nitrates of prolonged action were used. Simultaneous use of prazosin and emoxypin favoured balanced oxidant-antioxidant system of the body.
Document emailed within 1 workday
Related Documents
Rozdil'skaia, O.N.; Kaduk, I.G.; Biazrova, V.V. 1993: The use of sodium nitroprusside aerosols combined with ultrasound in the combined treatment of patients with ischemic heart disease and heart failure Likars'ka Sprava 4: 97-100Ageichenko, A.V.; Kalutsky, P.V.; Medvedeva, O.A.; Korolev, V.A. 2015: Changes in Colon Microbiocenosis Composition and Antioxidant Properties of Colonocytes Under the Condition of Experimental Dysbiosis and Emoxipin Prophylaxis Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2015(4): 84-88
Iwata, A.; Miura, S.-i.; Nishikawa, H.; Kawamura, A.; Matsuo, Y.; Sako, H.; Kumagai, K.; Matsuo, K.; Saku, K. 2006: Significance of combined angiotensin Ii receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant Journal of Cardiology 47(1): 1-7
Nepoklonov, M.V.; Rogoza, A.N.; Skvortsov, A.A.; Gorieva, S.B.; Tereshchenko, S.N. 2010: Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy Terapevticheskii Arkhiv 82(12): 73-80
Ko, Y.S.; Yang, S.Y.; Yian, W.K. 1990: Clinical significance of changes in the serum level of endogenous digitalis-like factor in patients with chronic congestive heart failure Zhonghua Nei Ke Za Zhi 29(1): 11-13; 59-60
Sasaki, T.; Kubo, T.; Miyamoto, T.; Komamura, K.; Honda, K.; Miyatake, K. 2001: Clinical significance of measuring inferior vena cava dimension in patients with acute exacerbation of chronic heart failure Journal of Cardiology 37(6): 309-313
Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Kikuchi, K.; Tanaka, H.; Gima, M.; Kashiwagi, Y.; Shida, H.; Kawamura, Y.; Hasebe, N. 2012: Abnormalities of magnesium (Mg) metabolism and therapeutic significance of Mg administration in patients with metabolic syndrome, type 2 diabetes, heart failure and chronic hemodialysis Clinical Calcium 22(8): 1217-1226
Kuch, M.; Janiszewski, M.; Janiszewski, M.ł; Braksator, W.; Mamcarz, A.; Sadkowska, K.; Kuch, J.; Dłuzniewski, M.ła. 2006: Prognostic value of symptoms and signs of advanced heart failure and low left ventricle ejection fraction in patients after myocardial infarction with chronic heart failure Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(117): 285-288
Cleland, J.G.; Dargie, H.J. 1986: Ventricular arrhythmias in heart failure; their significance and modification by amiodarone (with notes on the safety of combined therapy with captopril) British Journal of Clinical Practice. Supplement 44: 31-36
Simko, F.; Bada, V.; Simková, M.; Simko, J.; Kovács, L.; Hulín, I. 2002: The significance of aldosterone in chronic heart failure: the RALES study Vnitrni Lekarstvi 48(8): 767-772
Landström, N.; Kesek, M.; Jensen, S.M. 2013: Too few patients get heart failure pacemakers. it can provide better treatment in heart failure and left bundle branch block Lakartidningen 110(5): 216-219
Tarantini, L.; Cioffi, G.; Opasich, C.; Di Lenarda, A.; Pulignano, G.; Del Sindaco, D.; De Feo, S.; Stefenelli, C.; Russo, P.; Catania, G. 2004: Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(6): 441-449
Markiewicz, K.; Górski, L.; Broks-Bratkowska, B.; Cholewa, M. 1993: Effect of treatment with vasodilators on physical exercise tolerance in patients with chronic congestive heart failure Polski Tygodnik Lekarski 48(3-4): 61-64
Sazhina, E.I.; Kozlova, I.V.; Rebrov, A.P.; Al'tshuler, M.I. 2006: The degree of inflammation and endothelial dysfunction in treatment of chronic heart failure in patients with coronary artery disease Klinicheskaia Meditsina 84(12): 20-24
Mahgoub, A.A.; El-Medany, A.H.; Abdulatif, A.S. 2002: A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure Saudi Medical Journal 23(6): 725-731
Davie, A.; McMurray, J. 1999: Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation Circulation 99(22): 2966; Author Reply 2966-7
Csóvári, S.; Andyal, T.; Strenger, J. 1991: Determination of the antioxidant properties of the blood and their diagnostic significance in the elderly Laboratornoe Delo 10: 9-13
Aleksandrova, E.B. 2013: Chronic heart failure in patients with arterial hypertension and ischemic heart desease: age and gender characteristics Kardiologiia 53(7): 40-44
Akberova, S.I.; Musaev Galbinur, P.I.; Stroeva, O.G.; Magomedov, N.M.; Babaev, N.F.; Galbinur, A.P. 2001: Comparative evaluation of the antioxidant activity of para-aminobenzoic acid and emoxipin in the cornea and crystalline lens (an experimental study) Vestnik Oftalmologii 117(4): 25-29